{"id":"c2537","number":2317,"headline":{"en":"MDR-TB Breakthrough","da":"MDR-TB gennembrud"},"content":{"en":"MDR-TB Breakthrough: Routine drug susceptibility testing using MTBDRplus in South Africa has increased the identification of multidrug-resistant tuberculosis (MDR-TB) cases and improved culture conversion. Adding pncA sequencing to rpoB mutation analysis accurately detects pyrazinamide-resistant MDR-TB. The introduction of the Xpert MTB/RIF test has influenced the diagnosis and management of drug-resistant TB in KwaZulu-Natal, South Africa.","da":"MDR-TB gennembrud: Rutinemæssig lægemiddelsusceptibilitetstestning ved brug af MTBDRplus i Sydafrika har øget identificeringen af multidrug-resistent tuberkulose (MDR-TB) tilfælde og forbedret kulturkonversionen. Tilføjelse af pncA-sekventering til rpoB-mutationsanalyse opdager præcist pyrazinamid-resistent MDR-TB. Introduktionen af Xpert MTB/RIF-testen har påvirket diagnosen og håndteringen af lægemiddelresistent TB i KwaZulu-Natal, Sydafrika."},"bots":{"critic":{"en":null,"da":null},"potential":{"en":null,"da":null}}}